Vanguard Capital Wealth Advisors increased its holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 228.3% during the 1st quarter, Holdings Channel reports. The firm owned 75,500 shares of the company’s stock after buying an additional 52,500 shares during the period. Vanguard Capital Wealth Advisors’ holdings in Nautilus Biotechnology were worth $209,000 at the […]